| DC Field | Value | Language |
|---|
| dc.contributor.author | Zhunusov, N. S. | - |
| dc.date.accessioned | 2025-01-24T08:21:43Z | - |
| dc.date.available | 2025-01-24T08:21:43Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.citation | Zhunusov, N.S. Homozygous mice with mutant protein FUS[1-359] overexpression: Innovative possibilities for ALS treatment / N.S. Zhunusov // Research Results in Pharmacology. - 2024. - Vol.10, №4.-P. 137-141. - Doi: 10.18413/rrpharmacology.10.554. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/64421 | - |
| dc.description.abstract | This study investigates a mouse model with overexpression of the mutant FUS[1-359] protein, which can be used to evaluate the effectiveness of gene therapy and other pharmacological interventions for amyotrophic lateral sclerosis (ALS) | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | amyotrophic lateral sclerosis | ru |
| dc.subject | gene expression | ru |
| dc.subject | gene therapy | ru |
| dc.subject | mouse model | ru |
| dc.title | Homozygous mice with mutant protein FUS[1-359] overexpression: Innovative possibilities for ALS treatment | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 10, № 4
|
